Compound Detail
CHEMBL83
TAMOXIFEN 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL83 |
| Name | TAMOXIFEN |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | NKANXQFJJICGDU-QPLCGJKRSA-N |
| Therapeutic | ✓ Yes |
| Active Moiety | CHEMBL4525767 |
111
Targets
475
Activities
4
Assay Types
12
PK Parameters
20
Publications
8
Known Names
20
Indications
Molecular Properties
371.5
MW (Da)
6.00
ALogP
2
HBA
0
HBD
12.5
PSA (Ų)
0.45
QED
1
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1977 |
| Availability | Prescription |
| Chirality | Achiral |
Indications
Neoplasms Neoplasms Breast Neoplasms Breast Neoplasms Breast Neoplasms Breast Neoplasms, Male Carcinoma, Intraductal, Noninfiltrating Cognitive Dysfunction Coronary Disease Fallopian Tube Neoplasms Hot Flashes Hyperplasia Hypertension Infertility Menopause Muscular Dystrophy, Duchenne Myocardial Ischemia Neoplasm Metastasis Ovarian Neoplasms Ovarian Neoplasms
ATC Classification
L02BA01
tamoxifen
Level 1: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Level 2: ENDOCRINE THERAPY
Activity Summary
IC50 395 meas. best 8.82
Ki 58 meas. best 9.29
EC50 21 meas. best 9.96
Kd 1 meas. best 9.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| MCF7 CHEMBL387 | EC50 | 9.96 | 8.98 | 0.1 | 2 |
| Estrogen receptor beta CHEMBL242 | Ki | 9.29 | 9.29 | 0.5 | 1 |
| Anti-estrogen binding site (AEBS) CHEMBL612409 | Kd | 9.0 | 9.0 | 1.0 | 1 |
| Estrogen receptor CHEMBL206 | IC50 | 8.82 | 6.7348 | 1.5 | 33 |
| Emopamil-binding protein-like CHEMBL2311238 | Ki | 8.55 | 8.55 | 2.8 | 1 |
| 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase CHEMBL4931 | Ki | 8.3 | 8.3 | 5.0 | 1 |
| Sigma non-opioid intracellular receptor 1 CHEMBL287 | Ki | 8.06 | 7.76 | 8.7 | 2 |
| Estrogen receptor CHEMBL2093866 | Ki | 7.92 | 7.3933 | 11.9 | 3 |
| Anti-estrogen binding site (AEBS) CHEMBL612409 | IC50 | 7.92 | 7.92 | 12.0 | 1 |
| MCF7 CHEMBL387 | IC50 | 7.7 | 5.1915 | 20.0 | 110 |
| Sigma non-opioid intracellular receptor 1 CHEMBL287 | IC50 | 7.68 | 7.68 | 21.0 | 1 |
| Estrogen receptor CHEMBL206 | Ki | 7.51 | 7.51 | 31.2 | 1 |
| Ishikawa CHEMBL614649 | EC50 | 7.48 | 7.48 | 33.0 | 1 |
| MDA-MB-435 CHEMBL614697 | IC50 | 7.3 | 7.15 | 50.0 | 2 |
| Estrogen-related receptor gamma CHEMBL4245 | IC50 | 7.21 | 7.21 | 62.2 | 1 |
| Estrogen receptor beta CHEMBL242 | IC50 | 7.1 | 6.5375 | 79.7 | 12 |
| MDA-MB-231 CHEMBL400 | IC50 | 7.1 | 4.7917 | 80.0 | 41 |
| ATP-dependent translocase ABCB1 CHEMBL4302 | Ki | 7.0 | 7.0 | 100.0 | 1 |
| Zaire ebolavirus CHEMBL4513181 | IC50 | 7.0 | 7.0 | 100.0 | 1 |
| Progesterone receptor CHEMBL208 | IC50 | 6.89 | 6.89 | 128.8 | 1 |
| Ishikawa CHEMBL614649 | IC50 | 6.77 | 5.1867 | 170.0 | 9 |
| Cytochrome P450 3A4 CHEMBL340 | Ki | 6.7 | 6.7 | 200.0 | 1 |
| Steroid hormone receptor ERR1 CHEMBL3429 | IC50 | 6.7 | 6.7 | 200.0 | 1 |
| 5-hydroxytryptamine receptor 2C CHEMBL225 | Ki | 6.62 | 6.62 | 241.0 | 1 |
| Estrogen receptor CHEMBL2093866 | IC50 | 6.55 | 5.9989 | 280.0 | 9 |
| D(3) dopamine receptor CHEMBL234 | Ki | 6.44 | 6.44 | 364.0 | 1 |
| Unchecked CHEMBL612545 | Ki | 6.42 | 5.842 | 381.0 | 5 |
| 5-hydroxytryptamine receptor 2C CHEMBL225 | IC50 | 6.34 | 6.34 | 460.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 6.3 | 5.2263 | 503.0 | 16 |
| EL4 CHEMBL614293 | IC50 | 6.27 | 6.27 | 535.0 | 1 |
| Muscarinic acetylcholine receptor M3 CHEMBL245 | Ki | 6.2 | 6.2 | 630.0 | 1 |
| Muscarinic acetylcholine receptor M4 CHEMBL1821 | Ki | 6.17 | 6.17 | 672.0 | 1 |
| Muscarinic acetylcholine receptor M1 CHEMBL216 | Ki | 6.17 | 6.17 | 681.0 | 1 |
| Alpha-2A adrenergic receptor CHEMBL1867 | Ki | 6.14 | 6.14 | 726.0 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | Ki | 6.1 | 6.1 | 792.2 | 1 |
| Cytochrome P450 2B6 CHEMBL4729 | Ki | 6.05 | 6.05 | 900.0 | 1 |
| Thromboxane-A synthase CHEMBL1835 | IC50 | 6.04 | 6.04 | 916.0 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 6.01 | 5.905 | 967.0 | 2 |
| Protein kinase C (PKC) CHEMBL2093867 | IC50 | 6.0 | 5.35 | 1000.0 | 2 |
| T47D CHEMBL614361 | IC50 | 6.0 | 5.0843 | 1000.0 | 7 |
| 5-hydroxytryptamine receptor 6 CHEMBL3371 | Ki | 5.98 | 5.945 | 1041.0 | 2 |
| D(3) dopamine receptor CHEMBL234 | IC50 | 5.97 | 5.97 | 1072.0 | 1 |
| Tyrosine-protein kinase Fyn CHEMBL1841 | IC50 | 5.92 | 5.92 | 1195.0 | 1 |
| Sodium-dependent serotonin transporter CHEMBL228 | Ki | 5.91 | 5.91 | 1240.0 | 1 |
| Substance-K receptor CHEMBL2327 | Ki | 5.91 | 5.91 | 1223.0 | 1 |
| 5-hydroxytryptamine receptor 2B CHEMBL1833 | Ki | 5.88 | 5.88 | 1326.0 | 1 |
| 5-hydroxytryptamine receptor 2A CHEMBL224 | Ki | 5.86 | 5.86 | 1372.0 | 1 |
| Sodium-dependent noradrenaline transporter CHEMBL222 | Ki | 5.84 | 5.84 | 1459.0 | 1 |
| Sodium-dependent noradrenaline transporter CHEMBL222 | IC50 | 5.83 | 5.83 | 1472.0 | 1 |
| Sodium-dependent dopamine transporter CHEMBL238 | Ki | 5.83 | 5.83 | 1462.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | - | - | Mus musculus |
| CL | - | - | Homo sapiens |
| CL | - | - | Homo sapiens |
| CL | 12.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 33.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 95.0 | mL.min-1.kg-1 | Rattus norvegicus |
| Cmax | 296.0 | nM | Homo sapiens |
| F | 69.0 | % | Rattus norvegicus |
| KA | 2.1e-07 | M | - |
| t1/2 | - | - | Homo sapiens |
| T1/2 | 0.1483 | hr | Mus musculus |
| T1/2 | 1.0 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL3885861 | Rattus norvegicus | 1418 |
| - | 10.6019/CHEMBL3885881 | Rattus norvegicus | 841 |
| 32898794 | 10.1016/j.ejmech.2020.112775 | Unchecked | 25 |
| - | 10.6019/CHEMBL4295262 | Unchecked | 24 |
| 6431104 | 10.1021/jm00374a021 | Rattus norvegicus | 18 |
| 16472241 | 10.2174/1570163043334794 | Hepatotoxicity | 18 |
| 2995668 | 10.1021/jm00148a022 | Estrogen receptor | 14 |
| 22194678 | 10.1371/journal.pcbi.1002310 | Hepatotoxicity | 14 |
| 9216828 | 10.1021/jm970095o | Estrogen receptor | 13 |
| 18024584 | 10.1073/pnas.0709695104 | H4 | 12 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | Unchecked | 11 |
| 21777996 | 10.1016/j.ejmech.2011.07.005 | Albumin | 9 |
| 3950918 | 10.1021/jm00153a013 | MCF7 | 8 |
| 31884407 | 10.1016/j.ejmech.2019.111986 | MCF7 | 8 |
| 3806590 | 10.1021/jm00384a022 | MCF7 | 8 |
| 25740159 | 10.1016/j.bmcl.2015.02.013 | No relevant target | 8 |
| 9003514 | 10.1021/jm9606352 | Rattus norvegicus | 8 |
| 3950918 | 10.1021/jm00153a013 | Rattus norvegicus | 8 |
| 27128175 | 10.1016/j.ejmech.2016.03.090 | HeLa | 8 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | NON-PROTEIN TARGET | 8 |
Data from ChEMBL 36 via Core Engine